Company / Capital Expenditures
Centene Corporation Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$767.0M
FY2025
5-year range
$644.0M / $1.0B
FY2021-FY2025
Trend
+19.1%
vs FY2024
Sector context
#12 of 150
Health Care
What the data says
Among 150 Health Care companies, Centene Corporation is in the top 8% for capital expenditures. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $767M.
Based on SEC 10-K filings.
$767M in FY2025 with a 5-year CAGR of -2.5%. Top quartile in the Health Care sector.
Declined from $799M to $767M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -8.6%
- 5-Year CAGR
- -2.5%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 150This company $767.0M Sector average $271.1M
▼
+183.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -2.5%, indicating a declining trend.
- In FY2025, capital expenditures increased 19.1% year-over-year.
- Ranks #12 out of 150 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $767.0M | +19.1% |
| FY2024 | $644.0M | -19.4% |
| FY2023 | $799.0M | -20.4% |
| FY2022 | $1.0B | +10.3% |
| FY2021 | $910.0M | +4.7% |
| FY2020 | $869.0M | +19.0% |
| FY2019 | $730.0M | +8.1% |
| FY2018 | $675.0M | +60.0% |
| FY2017 | $422.0M | +37.9% |
| FY2016 | $306.0M | +104.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026